Mobile phone operator Vodafone has concluded its lengthy B2B PR
review, picking Harvard PR for the six-figure business.
Harvard won the brief - which is believed to be worth £250,000 in
fees - after a two-month long, four-stage pitch, managed by Agency
Incumbent consultancy Brodeur Worldwide took part in the final three-way
Harvard starts work on 1 February with a remit to oversee Vodafone's UK
business and technology PR, running both media and industry analyst
relations programmes. The account is led by Harvard director Simon
'We are specifically focusing on Vodafone's UK SME and corporate
customers and we'll be targeting business, whether they're five people
strong or FTSE 100 firms,' said Jones.
'The main challenge of the brief over the course of the next 12 months
is to communicate the actual deliverables that Vodafone's new technology
will bring to UK users - it's an educational job, getting across the
tangible benefits' he added.
Jones reports to Vodafone head of UK corporate comms Anna Cloke, who
joined the firm from One2One last August (PRWeek, 17 August 2001).
Harvard will work closely with Vodafone's in-house team and retained
consumer agency, Borkowski PR.
Newbury-based Vodafone has more than 12.8 million customers.
- Harvard Health this week picked up a six-figure brief from Johnson &
Johnson MSD to handle PR for its diarrhoea treatment Imodium.
Harvard has been tasked with positioning diarrhoea as 'an everyday
ordinary condition' that happens to everyone. Harvard Health director
Paul Jarman leads the brief, reporting to Imodium product manager Jacqui